Folic Acid Antagonists: Antimicrobial and Immunomodulating Mechanisms and Applications

Daniel Fernández-Villa1, Maria Rosa Aguilar2,3, Luis Rojo4,5

  • 1Instituto de Ciencia y Tecnología de Polímeros, Consejo Superior de Investigaciones Científicas, CSIC, 28006 Madrid, Spain. dafer-vi@hotmail.com.

Insights

Antifolates, drugs targeting microbial folate metabolism, are crucial for treating infections. Emerging drug resistance necessitates combined therapies and exploration of their immunomodulatory roles.

Area of Science:

  • Microbiology
  • Pharmacology
  • Immunology

Background:

  • Microbial infections exhibit accelerated metabolic rates, including folate metabolism, for replication and synthesis.
  • Folic acid antagonists exploit this metabolic difference to target microbial cells, differing from human cell metabolism.
  • Drug resistance to antifolates has emerged, leading to the clinical use of combination therapies.

Purpose of the Study:

  • To provide an updated review on antifolates as antibacterial and immunomodulating agents.
  • To detail the mechanisms of action for antifolates in clinical and research settings.
  • To present current and emerging biomedical applications of antifolates.

Main Methods:

  • Literature review of scientific journals and clinical studies.
  • Analysis of antifolate mechanisms of action against microbial and immune cells.
  • Synthesis of data on clinical applications and ongoing research.

Main Results:

  • Antifolates are effective against various microbial infections due to their targeted metabolic inhibition.
  • Some antifolates possess immunomodulatory properties, enabling use as anti-inflammatory or immunosuppressive agents.
  • Combined antifolate therapies are increasingly employed to overcome drug resistance.

Conclusions:

  • Antifolates remain vital in combating microbial infections and managing inflammatory/immune conditions.
  • Understanding antifolate mechanisms is key to developing novel therapeutic strategies.
  • Further research into antifolates' dual antibacterial and immunomodulatory roles promises expanded clinical utility.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.7K
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
12.9K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
443
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.4K
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
409
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
393